Search bioRxiv⌕ Search

Biology subjects

Idowu, E. T.

Publications and source records attributed to Idowu, E. T..

2 recordsLinked to original sources

Plasmo3Net: A Convolutional Neural Network-Based Algorithm for Detecting Malaria Parasites in Thin Blood Smear Images

Early diagnosis of malaria is crucial for effective control and elimination efforts. Microscopy is a reliable field-adaptable malaria diagnostic method. However, microscopy results are only as good as the quality of slides and images obtained from thick and thin smears. In this study, we developed deep learning algorithms to identify malaria-infected red blood cells (RBCs) in thin blood smears. Three algorithms were developed based on a convolutional neural network (CNN). The CNN was trained on 15,060 images and evaluated using 4,000 images. After a series of fine-tuning and hyperparameter optimization experiments, we selected the top-performing algorithm, which was named Plasmo3Net. The Plasmo3Net architecture was made up of 13 layers: three convolutional, three max-pooling, one flatten, four dropouts, and two fully connected layers, to obtain an accuracy of 99.3%, precision of 99.1%, recall of 99.6%, and F1 score of 99.3%. The maximum training accuracy of 99.5% and validation accuracy of 97.7% were obtained during the learning phase. Four pre-trained deep learning models (InceptionV3, VGG16, ResNet50, and ALexNet) were selected and trained alongside our model as baseline techniques for comparison due to their performance in malaria parasite identification. The topmost transfer learning model was the ResNet50 with 97.9% accuracy, 97.6% precision, 98.3 % recall, and 97.9% F1 score. The accuracy of the Plasmo3Net in malaria parasite identification highlights its potential for automated malaria diagnosis in the future. With additional validation using more extensive and diverse datasets, Plasmo3Net could evolve into a diagnostic workflow suitable for field applications.

bioinformatics↗

Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors

Malaria chemotherapy has been plagued by parasite resistance. Novel drugs must be continually explored for malaria treatment. Plasmodium falciparum requires host glucose for survival and proliferation. Protein involved in hexose permeation, P. falciparum hexose transporter 1 (PfHT1) is a potential drug target. We performed high throughput virtual screening of 21,352 small-molecule compounds against PfHT1. The stability of the lead compound complexes was evaluated via molecular dynamics (MD) simulation for 100 nanoseconds. We also investigated the pharmacodynamic, pharmacokinetic and physiological characteristics of the compounds in accordance with Lipinksi rules for drug-likeness to bind and inhibit PfHT1. Molecular docking and free binding energy analyses were carried out using Molecular Mechanics with Generalised Born and Surface Area (MMGBSA) solvation to determine the selectivity of the hit compounds for PfHT1 over the human glucose transporter (hGLUT1) orthologue. Five important compounds were identified: Hyperoside (CID5281643); avicularin (CID5490064); sylibin (CID5213); harpagoside (CID5481542) and quercetagetin (CID5281680). The compounds formed intermolecular interaction with the binding pocket of the target via conserved amino acid residues (Val314, Gly183, Thr49, Asn52, Gly183, Ser315, Ser317, and Asn48). The MMGBSA analysis of the complexes yielded high free binding energies. Four (CID5281643, CID5490064, CID5213, and CID5481542) of the identified compounds were found to be stable within the PfHT1 binding pocket throughout the 100 nanoseconds simulation run time. The four compounds demonstrated higher affinity for PfHT1 than the human major glucose transporter (hGLUT1). This investigation demonstrates the inhibition potential of sylibin, hyperoside, harpagoside, and avicularin against PfHT1 receptor. Robust preclinical investigations are required to validate the chemotherapeutic properties of the identified compounds.

bioinformatics↗